A 'Go-To' Treatment for Type 2 Diabetes?A 'Go-To' Treatment for Type 2 Diabetes?

Combining basal insulin with a GLP-1 inhibitor not only may produce favorable reductions in A1c values, but may also lower the risk for hypoglycemia and promote weight loss, reports Dr John Buse. Medscape Diabetes & Endocrinology
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology Commentary Source Type: news